semaglutide prescriptions How to Qualify for an Ozempic Prescription Ozempic This, Wegovy That: No

August 5, 2023: The European Medicines Agency (EMA) and other agencies are currently investigating whether there is a connection between the use of certain diabetes and weight loss drugs, such as Ozempic, Wegovy, and other glucagon-like peptide-1 (GLP-1) receptor agonists, and an increased risk of suicidal thoughts and self-harm

Retraction: Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus

While this is a new finding requiring continued monitoring, current evidence from both TRIUMPH-4 and TRIUMPH-1 suggests it's generally mild and not dangerous

The primary defendant in Ozempic lawsuits is Novo Nordisk , the Danish pharmaceutical company that manufactures and markets both Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management), both of which contain semaglutide